Bank of America
OCAT

Bank of America’s OCATA THERAPEUTICS, INC. COMMON STOCK OCAT Stock Holding History

Bank of America’s Portfolio OCAT Stock Details OCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-7,521
Closed -$63K – 7695
2015
Q4 		$63K Buy
7,521
+6,845
+1,013% +$45.8K ﹤0.01% 5946
2015
Q3 		$3K Sell
676
-29
-4% -$127 ﹤0.01% 6939
2015
Q2 		$4K Buy
+705
New +$4.52K ﹤0.01% 6936

Bank of America's OCAT Position: Q1 2016 in Review

Bank of America sold out of OCATA THERAPEUTICS, INC. COMMON STOCK (OCAT) in Q1 2016, closing a stake of 7,521 shares — an estimated $63K sold.

Bank of America first reported a position in OCAT in Q2 2015 and held it in 3 quarters. The position peaked at $63K in Q4 2015. 1 fund tracked by Wall St. Rank holds OCAT as of Q1 2016.

  • Bank of America reported no remaining OCATA THERAPEUTICS, INC. COMMON STOCK position as of Q1 2016 after selling out during the quarter.
  • Bank of America sold 7,521 OCATA THERAPEUTICS, INC. COMMON STOCK shares in Q1 2016, an estimated $63K.
  • Bank of America first reported a position in OCATA THERAPEUTICS, INC. COMMON STOCK in Q2 2015 and held it in 3 quarters.
  • Bank of America's OCATA THERAPEUTICS, INC. COMMON STOCK position peaked at $63K in Q4 2015.
  • 1 fund tracked by Wall St. Rank held OCATA THERAPEUTICS, INC. COMMON STOCK as of Q1 2016.

Based on Bank of America's 13F filing for Q1 2016, filed 13 May 2016.